Ser-249 p53 Mutations in Plasma DNA of Patients With Hepatocellular Carcinoma From The Gambia-Reference-Cited by-同舟云学术

Ser-249 p53 Mutations in Plasma DNA of Patients With Hepatocellular Carcinoma From The Gambia

Published:2000-01-19 Issue:2 Volume:92 Page:148-153
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Kirk Gregory D.,Camus-Randon Anne-Marie,Mendy Maimuna,Goedert James J.,Merle Philippe,Trépo Christian,Bréchot Christian,Hainaut Pierre,Montesano Ruggero

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/92/2/148/9996247/148.pdf

Reference45 articles.

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.

2. International Agency for Research on Cancer (IARC). Hepatitis viruses. Lyon (France): IARC Monogr Eval Carcinog Risks Hum, vol 59; 1994.

3. International Agency for Research on Cancer (IARC). Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon (France): IARC Monogr Eval Carcinog Risks Hum, vol 56; 1993. p. 245-395.

4. Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992;339:943-6.

5. Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 1994;3:3-10.

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis of the Initial Stage of Hepatocellular Carcinoma: A Review;Current Pharmaceutical Design;2024-06

2. Human TP53 gene polymorphisms among patients with Hepatocellular carcinoma and chronic hepatitis B infection in Kenya;F1000Research;2024-03-12

3. Biomarker in Hepatocellular Carcinoma;Indian Journal of Surgical Oncology;2024-01-02

4. Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma;Frontiers in Genetics;2023-08-01

5. Biomarkers of Exposure, Effect, and Susceptibility;Reference Module in Biomedical Sciences;2023